{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:10:26Z","timestamp":1788307826261,"version":"build-2803163510"},"reference-count":147,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,31]],"date-time":"2021-10-31T00:00:00Z","timestamp":1635638400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,31]],"date-time":"2021-10-31T00:00:00Z","timestamp":1635638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s10072-021-05662-9","type":"journal-article","created":{"date-parts":[[2021,10,31]],"date-time":"2021-10-31T19:02:30Z","timestamp":1635706950000},"page":"3-40","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":187,"title":["Spectrum of neurological complications following COVID-19 vaccination"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0044-7083","authenticated-orcid":false,"given":"Ravindra Kumar","family":"Garg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1132-5372","authenticated-orcid":false,"given":"Vimal Kumar","family":"Paliwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,31]]},"reference":[{"key":"5662_CR1","unstructured":"World Health Organization. 12 January 2021. WHO Coronavirus (COVID-19) Dashboard. &It; The World Health Organization https:\/\/covid19.who.int\/. Accessed 1 Aug\u00a02021."},{"key":"5662_CR2","unstructured":"Jeff Craven. 10 June 2021. COVID-19 vaccine tracker. &It; https:\/\/www.raps.org\/news-and-articles\/news-articles\/2020\/3\/covid-19-vaccine-tracker. Accessed 16 June 2021."},{"issue":"3","key":"5662_CR3","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1097\/00019052-200206000-00018","volume":"15","author":"S Piyasirisilp","year":"2002","unstructured":"Piyasirisilp S, Hemachudha T (2002) Neurological adverse events associated with vaccination. Curr Opin Neurol 15(3):333\u2013338","journal-title":"Curr Opin Neurol"},{"issue":"18","key":"5662_CR4","doi-asserted-by":"publisher","first-page":"685","DOI":"10.15585\/mmwr.mm7018e3","volume":"70","author":"AM Hause","year":"2021","unstructured":"Hause AM, Gee J, Johnson T et al (2021) Anxiety-related adverse event clusters after Janssen COVID-19 vaccination - five U.S. mass vaccination sites, April 2021. MMWR Morb Mortal Wkly Rep 70(18):685\u2013688","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"5662_CR5","doi-asserted-by":"publisher","first-page":"108786","DOI":"10.1016\/j.clim.2021.108786","volume":"229","author":"M Garc\u00eda-Grimshaw","year":"2021","unstructured":"Garc\u00eda-Grimshaw M, Ceballos-Liceaga SE, Hern\u00e1ndez-Vanegas LE et al (2021) Neurologic adverse events among 704,003 first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine in Mexico: a nationwide descriptive study. Clin Immunol 229:108786","journal-title":"Clin Immunol"},{"issue":"14","key":"5662_CR6","doi-asserted-by":"publisher","first-page":"e107","DOI":"10.3346\/jkms.2021.36.e107","volume":"36","author":"SH Kim","year":"2021","unstructured":"Kim SH, Wi YM, Yun SY et al (2021) Adverse events in healthcare workers after the first dose of ChAdOx1 nCoV-19 or BNT162b2 mRNA COVID-19 vaccination: a single center experience. J Korean Med Sci 36(14):e107","journal-title":"J Korean Med Sci"},{"issue":"21","key":"5662_CR7","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.3346\/jkms.2021.36.e153","volume":"36","author":"YW Lee","year":"2021","unstructured":"Lee YW, Lim SY, Lee JH et al (2021) Adverse reactions of the second dose of the BNT162b2 mRNA COVID-19 vaccine in healthcare workers in Korea. J Korean Med Sci. 36(21):e153","journal-title":"J Korean Med Sci."},{"key":"5662_CR8","doi-asserted-by":"crossref","unstructured":"G\u00f6bel CH, Heinze A, Karstedt S, et al. 2021 Headache attributed to vaccination against COVID-19 (coronavirus SARS-CoV-2) with the ChAdOx1 nCoV-19 (AZD1222) vaccine: a multicenter observational cohort study [published online ahead of print, 2021 Jul 27]. Pain Ther. 1\u201322.","DOI":"10.1007\/s40122-021-00296-3"},{"key":"5662_CR9","unstructured":"Module 3. Adverse events following immunization. https:\/\/www.who.int\/vaccine_safety\/initiative\/tech_support\/Part-3.pdf?ua=1. Accessed 19 June 2021."},{"issue":"2","key":"5662_CR10","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/ana.26160","volume":"90","author":"JH Ng","year":"2021","unstructured":"Ng JH, Chaudhuri KR, Tan EK (2021) Functional neurological disorders and COVID-19 vaccination. Ann Neurol 90(2):328","journal-title":"Ann Neurol"},{"issue":"7","key":"5662_CR11","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1001\/jamaneurol.2021.1042","volume":"78","author":"DD Kim","year":"2021","unstructured":"Kim DD, Kung CS, Perez DL (2021) Helping the public understand adverse events associated with COVID-19 vaccinations: lessons learned from functional neurological disorder. JAMA Neurol 78(7):789\u2013790","journal-title":"JAMA Neurol"},{"key":"5662_CR12","doi-asserted-by":"publisher","unstructured":"Butler M, Coebergh J, Safavi F, et al. 2021 Functional neurological disorder after SARS-CoV-2 vaccines: two case reports and discussion of potential public health implications [published online ahead of print, 2021 Jul 15]. J Neuropsychiatry Clin Neurosci. appineuropsych21050116. https:\/\/doi.org\/10.1176\/appi.neuropsych.21050116","DOI":"10.1176\/appi.neuropsych.21050116"},{"key":"5662_CR13","doi-asserted-by":"publisher","unstructured":"Ercoli T, Lutzoni L, Orofino G, Muroni A, Defazio G. 2021 Functional neurological disorder after COVID-19 vaccination [published online ahead of print, 2021 Jul 29]. Neurol Sci.;1\u20132. https:\/\/doi.org\/10.1007\/s10072-021-05504-8","DOI":"10.1007\/s10072-021-05504-8"},{"key":"5662_CR14","doi-asserted-by":"publisher","unstructured":"Iba T, Levy JH, Warkentin TE. 2021 Recognizing vaccine-induced immune thrombotic thrombocytopenia [published online ahead of print, 2021 Jul 13]. Crit Care Med.\u00a0https:\/\/doi.org\/10.1097\/CCM.0000000000005211","DOI":"10.1097\/CCM.0000000000005211"},{"key":"5662_CR15","doi-asserted-by":"publisher","unstructured":"Pomara C, Sessa F, Ciaccio M, et al. 2021 Post-mortem findings in vaccine-induced thrombotic thombocytopenia [published online ahead of print, 2021 May 20]. Haematologica.\u00a0https:\/\/doi.org\/10.3324\/haematol.2021.279075.","DOI":"10.3324\/haematol.2021.279075"},{"issue":"7855","key":"5662_CR16","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/d41586-021-00998-w","volume":"592","author":"H Ledford","year":"2021","unstructured":"Ledford H (2021) COVID vaccines and blood clots: five key questions. Nature 592(7855):495\u2013496","journal-title":"Nature"},{"key":"5662_CR17","doi-asserted-by":"publisher","first-page":"102662","DOI":"10.1016\/j.jaut.2021.102662","volume":"121","author":"D McGonagle","year":"2021","unstructured":"McGonagle D, De Marco G, Bridgewood C (2021) Mechanisms of Immunothrombosis in vaccine-induced thrombotic thrombocytopenia (VITT) compared to natural SARS-CoV-2 Infection. J Autoimmun 121:102662","journal-title":"J Autoimmun"},{"issue":"1","key":"5662_CR18","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s13054-021-03572-y","volume":"25","author":"GP Castelli","year":"2021","unstructured":"Castelli GP, Pognani C, Sozzi C, Franchini M, Vivona L (2021) Cerebral venous sinus thrombosis associated with thrombocytopenia post-vaccination for COVID-19. Crit Care 25(1):137. https:\/\/doi.org\/10.1186\/s13054-021-03572-y","journal-title":"Crit Care"},{"issue":"4","key":"5662_CR19","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3390\/jpm11040285","volume":"11","author":"V D'Agostino","year":"2021","unstructured":"D\u2019Agostino V, Caranci F, Negro A et al (2021) A rare case of cerebral venous thrombosis and disseminated intravascular coagulation temporally associated to the COVID-19 vaccine administration. J Pers Med 11(4):285. https:\/\/doi.org\/10.3390\/jpm11040285","journal-title":"J Pers Med"},{"issue":"23","key":"5662_CR20","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1056\/NEJMoa210538512","volume":"384","author":"M Scully","year":"2021","unstructured":"Scully M, Singh D, Lown R et al (2021) Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination. N Engl J Med 384(23):2202\u20132211. https:\/\/doi.org\/10.1056\/NEJMoa210538512","journal-title":"N Engl J Med"},{"key":"5662_CR21","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.thromres.2021.04.001","volume":"202","author":"M Franchini","year":"2021","unstructured":"Franchini M, Testa S, Pezzo M et al (2021) Cerebral venous thrombosis and thrombocytopenia post-COVID-19 vaccination. Thromb Res 202:182\u2013183. https:\/\/doi.org\/10.1016\/j.thromres.2021.04.001","journal-title":"Thromb Res"},{"key":"5662_CR22","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.bbi.2021.04.006.11","volume":"95","author":"PR Mehta","year":"2021","unstructured":"Mehta PR, Apap Mangion S, Benger M et al (2021) Cerebral venous sinus thrombosis and thrombocytopenia after COVID-19 vaccination - a report of two UK cases. Brain Behav Immun 95:514\u2013517. https:\/\/doi.org\/10.1016\/j.bbi.2021.04.006.11","journal-title":"Brain Behav Immun"},{"issue":"9","key":"5662_CR23","doi-asserted-by":"publisher","first-page":"e870","DOI":"10.1097\/CCM.0000000000005105","volume":"49","author":"S Bersinger","year":"2021","unstructured":"Bersinger S, Lagarde K, Marlu R, Pernod G, Payen JF (2021) Using nonheparin anticoagulant to treat a near-fatal case with multiple venous thrombotic lesions during ChAdOx1 nCoV-19 vaccination-related vaccine-induced immune thrombotic thrombocytopenia. Crit Care Med 49(9):e870\u2013e873. https:\/\/doi.org\/10.1097\/CCM.0000000000005105","journal-title":"Crit Care Med"},{"key":"5662_CR24","doi-asserted-by":"publisher","unstructured":"Ramdeny S, Lang A, Al-Izzi S, Hung A, Anwar I, Kumar P. Management of a patient with a rare congenital limb malformation syndrome after SARS-CoV-2 vaccine-induced thrombosis and thrombocytopenia (VITT) [published online ahead of print, 2021 Jun 7]. Br J Haematol. 2021.\u00a0https:\/\/doi.org\/10.1111\/bjh.17619.","DOI":"10.1111\/bjh.17619"},{"issue":"8","key":"5662_CR25","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1007\/s00701-021-04860-w","volume":"163","author":"Z Zakaria","year":"2021","unstructured":"Zakaria Z, Sapiai NA, Ghani ARI (2021) Cerebral venous sinus thrombosis 2 weeks after the first dose of mRNA SARS-CoV-2 vaccine. Acta Neurochir (Wien) 163(8):2359\u20132362. https:\/\/doi.org\/10.1007\/s00701-021-04860-w","journal-title":"Acta Neurochir (Wien)"},{"issue":"3","key":"5662_CR26","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/bjh.17530","volume":"194","author":"E Ryan","year":"2021","unstructured":"Ryan E, Benjamin D, McDonald I et al (2021) AZD1222 vaccine-related coagulopathy and thrombocytopenia without thrombosis in a young female. Br J Haematol 194(3):553\u2013556. https:\/\/doi.org\/10.1111\/bjh.17530","journal-title":"Br J Haematol"},{"key":"5662_CR27","doi-asserted-by":"publisher","unstructured":"Graf T, Thiele T, Klingebiel R, Greinacher A, Sch\u00e4bitz WR, Greeve I. 2021 Immediate high-dose intravenous immunoglobulins followed by direct thrombin-inhibitor treatment is crucial for survival in Sars-Covid-19-adenoviral vector vaccine-induced immune thrombotic thrombocytopenia VITT with cerebral sinus venous and portal vein thrombosis [published online ahead of print, May 22]. J Neurol. 2021;1\u20133.\u00a0https:\/\/doi.org\/10.1007\/s00415-021-10599-2","DOI":"10.1007\/s00415-021-10599-2"},{"key":"5662_CR28","doi-asserted-by":"publisher","unstructured":"George G, Friedman KD, Curtis BR, Lind SE. 2021 Successful treatment of thrombotic thrombocytopenia with cerebral sinus venous thrombosis following Ad26.COV2.S vaccination [published online ahead of print, 2021 May 14]. Am J Hematol. https:\/\/doi.org\/10.1002\/ajh.26237.","DOI":"10.1002\/ajh.26237"},{"issue":"7","key":"5662_CR29","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1007\/s00134-021-06425-y","volume":"47","author":"M Jamme","year":"2021","unstructured":"Jamme M, Mosnino E, Hayon J, Franchineau G (2021) Fatal cerebral venous sinus thrombosis after COVID-19 vaccination. Intensive Care Med 47(7):790\u2013791. https:\/\/doi.org\/10.1007\/s00134-021-06425-y","journal-title":"Intensive Care Med"},{"key":"5662_CR30","doi-asserted-by":"publisher","unstructured":"Tiede A, Sachs UJ, Czwalinna A, et al. Prothrombotic immune thrombocytopenia after COVID-19 vaccine [published online ahead of print, 2021 Apr 28]. Blood. 2021;blood.2021011958. https:\/\/doi.org\/10.1182\/blood.2021011958. 13","DOI":"10.1182\/blood.2021011958"},{"key":"5662_CR31","doi-asserted-by":"publisher","unstructured":"Schulz JB, Berlit P, Diener HC, Gerloff C, Greinacher A, Klein C. 2021 COVID-19 vaccine-associated cerebral venous thrombosis in Germany. medRxiv.04.30.21256383; doi: https:\/\/doi.org\/10.1101\/2021.04.30.21256383. 14","DOI":"10.1101\/2021.04.30.21256383"},{"key":"5662_CR32","doi-asserted-by":"publisher","unstructured":"Bourguignon A, Arnold DM, Warkentin TE, et al. 2021 Adjunct immune globulin for vaccine-induced thrombotic thrombocytopenia [published online ahead of print, 2021 Jun 9]. N Engl J Med.\u00a0https:\/\/doi.org\/10.1056\/NEJMoa2107051.","DOI":"10.1056\/NEJMoa2107051"},{"key":"5662_CR33","doi-asserted-by":"publisher","unstructured":"Gattringer T, Gressenberger P, Gary T, W\u00f6lfler A, Kneihsl M, Raggam RB. 2021 Successful management of vaccine-induced immune thrombotic thrombocytopenia-related cerebral sinus venous thrombosis after ChAdOx1 nCov-19 vaccination [published online ahead of print, 2021 Jul 8]. Stroke Vasc Neurol.svn-2021\u2013001142.\u00a0https:\/\/doi.org\/10.1136\/svn-2021-001142","DOI":"10.1136\/svn-2021-001142"},{"key":"5662_CR34","doi-asserted-by":"publisher","first-page":"svn-2021","DOI":"10.1136\/svn-2021-001095","volume":"8","author":"B Ikenberg","year":"2021","unstructured":"Ikenberg B, Demleitner AF, Thiele T et al (2021) Cerebral venous sinus thrombosis after ChAdOx1 nCov-19 vaccination with a misleading first cerebral MRI scan. Stroke Vasc Neurol 8:svn-2021-001095. https:\/\/doi.org\/10.1136\/svn-2021-001095","journal-title":"Stroke Vasc Neurol"},{"issue":"21","key":"5662_CR35","doi-asserted-by":"publisher","first-page":"00342 5","DOI":"10.1016\/j.annemergmed.2021.04.035","volume":"S0196 0644","author":"RT Clark","year":"2021","unstructured":"Clark RT, Johnson L, Billotti J et al (2021) Early outcomes of bivalirudin therapy for thrombotic thrombocytopenia and cerebral venous sinus thrombosis after Ad26.COV2.S vaccination. Ann Emerg Med S0196 0644(21):00342 5. https:\/\/doi.org\/10.1016\/j.annemergmed.2021.04.035","journal-title":"Ann Emerg Med"},{"key":"5662_CR36","doi-asserted-by":"publisher","unstructured":"Bonato S, Artoni A, Lecchi A, et al. 2021 Massive cerebral venous thrombosis due to vaccine-induced immune thrombotic thrombocytopenia [published online ahead of print, 2021 Jul 15]. Haematologica.\u00a0https:\/\/doi.org\/10.3324\/haematol.2021.279246","DOI":"10.3324\/haematol.2021.279246"},{"key":"5662_CR37","doi-asserted-by":"publisher","first-page":"hcab185","DOI":"10.1093\/qjmed\/hcab185","volume":"10","author":"RL Wang","year":"2021","unstructured":"Wang RL, Chiang WF, Shyu HY et al (2021) COVID-19 vaccine-associated acute cerebral venous thrombosis and pulmonary artery embolism. QJM 10:hcab185. https:\/\/doi.org\/10.1093\/qjmed\/hcab185","journal-title":"QJM"},{"issue":"4","key":"5662_CR38","doi-asserted-by":"publisher","first-page":"102184","DOI":"10.1016\/j.dsx.2021.06.021","volume":"15","author":"A Dutta","year":"2021","unstructured":"Dutta A, Ghosh R, Bhattacharya D et al (2021) Anti-PF4 antibody negative cerebral venous sinus thrombosis without thrombocytopenia following immunization with COVID-19 vaccine in an elderly non-comorbid Indian male, managed with conventional heparin-warfarin based anticoagulation. Diabetes Metab Syndr 15(4):102184. https:\/\/doi.org\/10.1016\/j.dsx.2021.06.021","journal-title":"Diabetes Metab Syndr"},{"issue":"9","key":"5662_CR39","doi-asserted-by":"publisher","first-page":"105938","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.105938","volume":"30","author":"Y Aladdin","year":"2021","unstructured":"Aladdin Y, Algahtani H, Shirah B (2021) Vaccine-induced immune thrombotic thrombocytopenia with disseminated intravascular coagulation and death following the ChAdOx1 nCoV-19 Vaccine. J Stroke Cerebrovasc Dis 30(9):105938. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2021.105938","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"5662_CR40","doi-asserted-by":"publisher","unstructured":"Lavin M, Elder PT, O'Keeffe D, et al. Vaccine-induced immune thrombotic thrombocytopenia (VITT) - a novel clinico-pathological entity with heterogeneous clinical presentations [published online ahead of print, 2021 Jun 22]. Br J Haematol. 2021.\u00a0https:\/\/doi.org\/10.1111\/bjh.17613.","DOI":"10.1111\/bjh.17613"},{"issue":"12","key":"5662_CR41","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1182\/bloodadvances.2021004904","volume":"5","author":"AL T\u00f8lb\u00f8ll S\u00f8rensen","year":"2021","unstructured":"T\u00f8lb\u00f8ll S\u00f8rensen AL, Rolland M, Hartmann J et al (2021) A case of thrombocytopenia and multiple thromboses after vaccination with ChAdOx1 nCoV-19 against SARS-CoV-2. Blood Adv 5(12):2569\u20132574. https:\/\/doi.org\/10.1182\/bloodadvances.2021004904","journal-title":"Blood Adv"},{"issue":"9","key":"5662_CR42","doi-asserted-by":"publisher","first-page":"E357","DOI":"10.1002\/ajh.26272","volume":"96","author":"BE Fan","year":"2021","unstructured":"Fan BE, Shen JY, Lim XR et al (2021) Cerebral venous thrombosis post BNT162b2 mRNA SARS-CoV-2 vaccination: a black swan event. Am J Hematol 96(9):E357\u2013E361. https:\/\/doi.org\/10.1002\/ajh.26272","journal-title":"Am J Hematol"},{"issue":"6","key":"5662_CR43","doi-asserted-by":"publisher","first-page":"e243931","DOI":"10.1136\/bcr-2021-243931","volume":"14","author":"P Suresh","year":"2021","unstructured":"Suresh P, Petchey W (2021) ChAdOx1 nCOV-19 vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis (CVST). BMJ Case Rep 14(6):e243931. https:\/\/doi.org\/10.1136\/bcr-2021-243931","journal-title":"BMJ Case Rep"},{"issue":"8","key":"5662_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.105906","volume":"30","author":"L Dias","year":"2021","unstructured":"Dias L, Soares-Dos-Reis R, Meira J et al (2021) Cerebral venous thrombosis after BNT162b2 mRNA SARS-CoV-2 vaccine. J Stroke Cerebrovasc Dis 30(8):105906. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2021.105906","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"5662_CR45","doi-asserted-by":"publisher","unstructured":"Guan CY, Tsai SH, Fan JS, Lin YK, Kao CC. 2021 A rare case of a middle-age Asian male with cerebral venous thrombosis after COVID-19 AstraZeneca vaccination [published online ahead of print, Jul 8]. Am J Emerg Med. 2021;S0735\u20136757(21)00571\u20134.\u00a0https:\/\/doi.org\/10.1016\/j.ajem.2021.07.011","DOI":"10.1016\/j.ajem.2021.07.011"},{"key":"5662_CR46","doi-asserted-by":"publisher","unstructured":"Varona JF, Garc\u00eda-Isidro M, Moeinvaziri M, Ramos-L\u00f3pez M, Fern\u00e1ndez-Dom\u00ednguez M. 2021 Primary adrenal insufficiency associated with Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia (VITT) [published online ahead of print, Jul 10]. Eur J Intern Med. 2021;S0953\u20136205(21)00236\u20133.\u00a0https:\/\/doi.org\/10.1016\/j.ejim.2021.06.025","DOI":"10.1016\/j.ejim.2021.06.025"},{"key":"5662_CR47","doi-asserted-by":"publisher","first-page":"n1114","DOI":"10.1136\/bmj.n1114","volume":"373","author":"A Potteg\u00e5rd","year":"2021","unstructured":"Potteg\u00e5rd A, Lund LC, Karlstad \u00d8 et al (2021) Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study. BMJ 373:n1114. https:\/\/doi.org\/10.1136\/bmj.n1114","journal-title":"BMJ"},{"issue":"11","key":"5662_CR48","doi-asserted-by":"publisher","first-page":"3656","DOI":"10.1111\/ene.15029","volume":"28","author":"K Krzywicka","year":"2021","unstructured":"Krzywicka K, Heldner MR, S\u00e1nchez van Kammen M et al (2021) Post-SARS-CoV-2-vaccination cerebral venous sinus thrombosis: an analysis of cases notified to the European Medicines Agency. Eur J Neurol 28(11):3656\u20133662. https:\/\/doi.org\/10.1111\/ene.15029","journal-title":"Eur J Neurol"},{"key":"5662_CR49","unstructured":"National Institute for Health and Care Excellence. 29 July 2021. COVID-19 rapid guideline: vaccine-induced immune thrombocytopenia and thrombosis (VTT). &It; https:\/\/www.nice.org.uk\/guidance\/ng200\/resources\/covid19-rapid-guideline-vaccineinduced-immune-thrombocytopenia-and-thrombosis-vitt-pdf-51036811744. Accessed 2 Aug\u00a02021."},{"issue":"11","key":"5662_CR50","doi-asserted-by":"publisher","first-page":"3656 3662","DOI":"10.1111\/ene.15029","volume":"28","author":"K Krzywicka","year":"2021","unstructured":"Krzywicka K, Heldner MR, S\u00e1nchez van Kammen M et al (2021) Post-SARS-CoV-2-vaccination cerebral venous sinus thrombosis: an analysis of cases notified to the European Medicines Agency. Eur J Neurol 28(11):3656 3662. https:\/\/doi.org\/10.1111\/ene.15029","journal-title":"Eur J Neurol"},{"issue":"9","key":"5662_CR51","doi-asserted-by":"publisher","first-page":"e870","DOI":"10.1097\/CCM.0000000000005105","volume":"49","author":"S Bersinger","year":"2021","unstructured":"Bersinger S, Lagarde K, Marlu R, Pernod G, Payen JF (2021) Using nonheparin anticoagulant to treat a near-fatal case with multiple venous thrombotic lesions during ChAdOx1 nCoV-19 vaccination-related vaccine-induced immune thrombotic thrombocytopenia. Crit Care Med 49(9):e870\u2013e873. https:\/\/doi.org\/10.1097\/CCM.0000000000005105","journal-title":"Crit Care Med"},{"issue":"7","key":"5662_CR52","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1038\/s41591-021-01408-4","volume":"27","author":"CR Simpson","year":"2021","unstructured":"Simpson CR, Shi T, Vasileiou E et al (2021) First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland. Nat Med 27(7):1290\u20131297. https:\/\/doi.org\/10.1038\/s41591-021-01408-4","journal-title":"Nat Med"},{"key":"5662_CR53","doi-asserted-by":"publisher","unstructured":"Athyros VG, Doumas M. 2021 A possible case of hypertensive crisis with intracranial haemorrhage after an mRNA Anti-COVID-19 vaccine [published online ahead of print, 2021 May 21]. Angiology.;33197211018323.\u00a0https:\/\/doi.org\/10.1177\/00033197211018323","DOI":"10.1177\/00033197211018323"},{"key":"5662_CR54","doi-asserted-by":"publisher","unstructured":"Bj\u00f8rnstad-Tuveng TH, Rudjord A, Anker P. 2021 Fatal cerebral haemorrhage after COVID-19 vaccine. Fatal hjernebl\u00f8dning etter covid-19-vaksine. Tidsskr Nor Laegeforen. 2021;141.\u00a0https:\/\/doi.org\/10.4045\/tidsskr.21.0312.","DOI":"10.4045\/tidsskr.21.0312"},{"key":"5662_CR55","doi-asserted-by":"publisher","unstructured":"de M\u00e9lo Silva ML Jr, Lopes DP. 2021 Large hemorrhagic stroke after ChAdOx1 nCoV-19 vaccination: a case report [published online ahead of print, 2021 Jul 17]. Acta Neurol Scand.\u00a0https:\/\/doi.org\/10.1111\/ane.13505.","DOI":"10.1111\/ane.13505"},{"issue":"10285","key":"5662_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00872-2","volume":"397","author":"A Bayas","year":"2021","unstructured":"Bayas A, Menacher M, Christ M, Behrens L, Rank A, Naumann M (2021) Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination. Lancet 397(10285):e11. https:\/\/doi.org\/10.1016\/S0140-6736(21)00872-2","journal-title":"Lancet"},{"issue":"11","key":"5662_CR57","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1136\/jnnp-2021-326984","volume":"92","author":"T Al-Mayhani","year":"2021","unstructured":"Al-Mayhani T, Saber S, Stubbs MJ et al (2021) Ischaemic stroke as a presenting feature of ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia. J Neurol Neurosurg Psychiatry 92(11):1247\u20131248. https:\/\/doi.org\/10.1136\/jnnp-2021-326984","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"5662_CR58","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1111\/jth.15347","volume":"19","author":"RA Blauenfeldt","year":"2021","unstructured":"Blauenfeldt RA, Kristensen SR, Ernstsen SL, Kristensen CCH, Simonsen CZ, Hvas AM (2021) Thrombocytopenia with acute ischemic stroke and bleeding in a patient newly vaccinated with an adenoviral vector-based COVID-19 vaccine. J Thromb Haemost 19(7):1771\u20131775. https:\/\/doi.org\/10.1111\/jth.15347","journal-title":"J Thromb Haemost"},{"issue":"7","key":"5662_CR59","doi-asserted-by":"publisher","first-page":"e243975","DOI":"10.1136\/bcr-2021-243975","volume":"14","author":"B Malik","year":"2021","unstructured":"Malik B, Kalantary A, Rikabi K, Kunadi A (2021) Pulmonary embolism, transient ischaemic attack and thrombocytopenia after the Johnson & Johnson COVID-19 vaccine. BMJ Case Rep. 14(7):e243975. https:\/\/doi.org\/10.1136\/bcr-2021-243975","journal-title":"BMJ Case Rep."},{"key":"5662_CR60","doi-asserted-by":"publisher","unstructured":"Finsterer J, Korn M. 2021 Aphasia seven days after second dose of an mRNA-based SARS-CoV-2 vaccine [published online ahead of print, 2021 Jun 24]. Brain Hemorrhages.\u00a0https:\/\/doi.org\/10.1016\/j.hest.2021.06.001.","DOI":"10.1016\/j.hest.2021.06.001"},{"key":"5662_CR61","doi-asserted-by":"publisher","unstructured":"Walter U, Fuchs M, Grossmann A, et al. 2021 Adenovirus-vectored COVID-19 vaccine-induced immune thrombosis of carotid artery: a case report [published online ahead of print, 2021 Jul 26]. Neurology. https:\/\/doi.org\/10.1212\/WNL.0000000000012576.","DOI":"10.1212\/WNL.0000000000012576"},{"key":"5662_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2021.577661","volume":"358","author":"L Baldelli","year":"2021","unstructured":"Baldelli L, Amore G, Montini A et al (2021) Hyperacute reversible encephalopathy related to cytokine storm following COVID-19 vaccine. J Neuroimmunol 358:577661. https:\/\/doi.org\/10.1016\/j.jneuroim.2021.577661","journal-title":"J Neuroimmunol"},{"key":"5662_CR63","doi-asserted-by":"publisher","first-page":"577629","DOI":"10.1016\/j.jneuroim.2021.577629","volume":"357","author":"Y Aladdin","year":"2021","unstructured":"Aladdin Y, Shirah B (2021) New-onset refractory status epilepticus following the ChAdOx1 nCoV-19 vaccine. J Neuroimmunol 357:577629. https:\/\/doi.org\/10.1016\/j.jneuroim.2021.577629","journal-title":"J Neuroimmunol"},{"issue":"3","key":"5662_CR64","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.dsx.2021.05.003","volume":"15","author":"R Ghosh","year":"2021","unstructured":"Ghosh R, Dubey S, Roy D, Mandal A, Naga D, Benito-Le\u00f3n J (2021) Focal onset non-motor seizure following COVID-19 vaccination: a mere coincidence? Diabetes Metab Syndr 15(3):1023\u20131024. https:\/\/doi.org\/10.1016\/j.dsx.2021.05.003","journal-title":"Diabetes Metab Syndr"},{"issue":"7","key":"5662_CR65","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.16172","volume":"13","author":"BD Liu","year":"2021","unstructured":"Liu BD, Ugloini C, Jha P (2021) Two cases of post-Moderna COVID-19 vaccine encephalopathy associated with nonconvulsive status epilepticus. Cureus 13(7):e16172. https:\/\/doi.org\/10.7759\/cureus.16172","journal-title":"Cureus"},{"key":"5662_CR66","doi-asserted-by":"publisher","unstructured":"Naharci MI, Tasci I. 2021 Delirium in a patient with Alzheimer\u2019s dementia following COVID-19 vaccination [published online ahead of print, 2021 Jul 10]. Psychogeriatrics.\u00a0https:\/\/doi.org\/10.1111\/psyg.12747.","DOI":"10.1111\/psyg.12747"},{"key":"5662_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.prdoa.2021.100098","volume":"4","author":"MR Salinas","year":"2021","unstructured":"Salinas MR, Dieppa M (2021) Transient akathisia after the SARS-Cov-2 vaccine. Clin Park Relat Disord 4:100098. https:\/\/doi.org\/10.1016\/j.prdoa.2021.100098","journal-title":"Clin Park Relat Disord"},{"issue":"6","key":"5662_CR68","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/ggi.14163","volume":"21","author":"LF Zavala-Jonguitud","year":"2021","unstructured":"Zavala-Jonguitud LF, P\u00e9rez-Garc\u00eda CC (2021) Delirium triggered by COVID-19 vaccine in an elderly patient. Geriatr Gerontol Int 21(6):540. https:\/\/doi.org\/10.1111\/ggi.14163","journal-title":"Geriatr Gerontol Int"},{"key":"5662_CR69","doi-asserted-by":"publisher","unstructured":"Alfishawy M, Bitar Z, Elgazzar A, Elzoueiry M. 2021 Neuroleptic malignant syndrome following COVID-19 vaccination [published online ahead of print, Feb 20]. Am J Emerg Med. 2021;S0735\u20136757(21)00117\u20130. https:\/\/doi.org\/10.1016\/j.ajem.2021.02.011","DOI":"10.1016\/j.ajem.2021.02.011"},{"issue":"4","key":"5662_CR70","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s13760-021-01699-x","volume":"121","author":"G Ozgen Kenangil","year":"2021","unstructured":"Ozgen Kenangil G, Ari BC, Guler C, Demir MK (2021) Acute disseminated encephalomyelitis-like presentation after an inactivated coronavirus vaccine. Acta Neurol Belg 121(4):1089\u20131091. https:\/\/doi.org\/10.1007\/s13760-021-01699-x","journal-title":"Acta Neurol Belg"},{"key":"5662_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13760-021-01608-2","volume":"1","author":"L Cao","year":"2021","unstructured":"Cao L, Ren L (2021) Acute disseminated encephalomyelitis after severe acute respiratory syndrome coronavirus 2 vaccination: a case report. Acta Neurol Belg 1:1\u20133. https:\/\/doi.org\/10.1007\/s13760-021-01608-2","journal-title":"Acta Neurol Belg"},{"key":"5662_CR72","doi-asserted-by":"publisher","unstructured":"Raknuzzaman M, Jannaty T, Hossain MB, Saha B, Dey SK, Shahidullah M. 2021 Post Covid 19 vaccination acute disseminated encephalomyelitis: a case report in Bangladesh. Int J Med Sci Clin Res Studies 3.\u00a0https:\/\/doi.org\/10.47191\/ijmscrs\/v1-i3-01","DOI":"10.47191\/ijmscrs\/v1-i3-01"},{"issue":"7","key":"5662_CR73","doi-asserted-by":"publisher","first-page":"e243173","DOI":"10.1136\/bcr-2021-243173","volume":"14","author":"G Torrealba-Acosta","year":"2021","unstructured":"Torrealba-Acosta G, Martin JC, Huttenbach Y et al (2021) Acute encephalitis, myoclonus and Sweet syndrome after mRNA-1273 vaccine. BMJ Case Rep 14(7):e243173. https:\/\/doi.org\/10.1136\/bcr-2021-243173","journal-title":"BMJ Case Rep"},{"key":"5662_CR74","doi-asserted-by":"publisher","first-page":"106839","DOI":"10.1016\/j.clineuro.2021.106839","volume":"208","author":"A Vogrig","year":"2021","unstructured":"Vogrig A, Janes F, Gigli GL (2021) Acute disseminated encephalomyelitis after SARS-CoV-2 vaccination. Clin Neurol Neurosurg 208:106839. https:\/\/doi.org\/10.1016\/j.clineuro.2021.106839","journal-title":"Clin Neurol Neurosurg"},{"issue":"3","key":"5662_CR75","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1002\/ana.26182","volume":"90","author":"F Zuhorn","year":"2021","unstructured":"Zuhorn F, Graf T, Klingebiel R, Sch\u00e4bitz WR, Rogalewski A (2021) Postvaccinal encephalitis after ChAdOx1 nCov-19. Ann Neurol 90(3):506\u2013511. https:\/\/doi.org\/10.1002\/ana.26182","journal-title":"Ann Neurol"},{"issue":"10","key":"5662_CR76","doi-asserted-by":"publisher","first-page":"e77766","DOI":"10.1371\/journal.pone.0077766","volume":"8","author":"P Pellegrino","year":"2013","unstructured":"Pellegrino P, Carnovale C, Perrone V et al (2013) Acute disseminated encephalomyelitis onset: evaluation based on vaccine adverse events reporting systems. PLoS One 8(10):e77766. https:\/\/doi.org\/10.1371\/journal.pone.0077766","journal-title":"PLoS One"},{"key":"5662_CR77","doi-asserted-by":"publisher","unstructured":"Malhotra SH, Gupta P, Prabhu V, Garg RK, Dandu H, Agarwal V. COVID-19 vaccination-associated myelitis [published online ahead of print, 2021 Mar 31]. QJM. 2021;hcab069. https:\/\/doi.org\/10.1093\/qjmed\/hcab069","DOI":"10.1093\/qjmed\/hcab069"},{"key":"5662_CR78","doi-asserted-by":"publisher","unstructured":"Fitzsimmons, William and Nance, Christopher S., Sudden onset of myelitis after COVID-19 vaccination: an under-recognized severe rare adverse event (May 5, 2021). Available at SSRN: https:\/\/ssrn.com\/abstract=3841558 or\u00a0https:\/\/doi.org\/10.2139\/ssrn.3841558","DOI":"10.2139\/ssrn.3841558"},{"issue":"7","key":"5662_CR79","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.16624","volume":"13","author":"N Tahir","year":"2021","unstructured":"Tahir N, Koorapati G, Prasad S et al (2021) SARS-CoV-2 vaccination-induced transverse myelitis. Cureus 13(7):e16624. https:\/\/doi.org\/10.7759\/cureus.16624","journal-title":"Cureus"},{"key":"5662_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2021.577606","volume":"358","author":"C Pagenkopf","year":"2021","unstructured":"Pagenkopf C, S\u00fcdmeyer M (2021) A case of longitudinally extensive transverse myelitis following vaccination against Covid-19. J Neuroimmunol 358:577606. https:\/\/doi.org\/10.1016\/j.jneuroim.2021.577606","journal-title":"J Neuroimmunol"},{"key":"5662_CR81","doi-asserted-by":"publisher","unstructured":"Helmchen C, Buttler GM, Markewitz R, Hummel K, Wiendl H, Boppel T. 2021 Acute bilateral optic\/chiasm neuritis with longitudinal extensive transverse myelitis in longstanding stable multiple sclerosis following vector-based vaccination against the SARS-CoV-2 [published online ahead of print, Jun 15]. J Neurol. 2021;1\u20136.\u00a0https:\/\/doi.org\/10.1007\/s00415-021-10647-x","DOI":"10.1007\/s00415-021-10647-x"},{"key":"5662_CR82","doi-asserted-by":"publisher","unstructured":"Havla J, Schultz Y, Zimmermann H, Hohlfeld R, Danek A, K\u00fcmpfel T. 2021 First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine [published online ahead of print, 2021 Jun 11]. J Neurol. 1\u20134.\u00a0https:\/\/doi.org\/10.1007\/s00415-021-10648-w","DOI":"10.1007\/s00415-021-10648-w"},{"issue":"9","key":"5662_CR83","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.1007\/s10072-021-05427-4","volume":"42","author":"S Chen","year":"2021","unstructured":"Chen S, Fan XR, He S, Zhang JW, Li SJ (2021) Watch out for neuromyelitis optica spectrum disorder after inactivated virus vaccination for COVID-19. Neurol Sci 42(9):3537\u20133539. https:\/\/doi.org\/10.1007\/s10072-021-05427-4","journal-title":"Neurol Sci"},{"issue":"3","key":"5662_CR84","doi-asserted-by":"publisher","first-page":"JC29","DOI":"10.7326\/ACPJ202103160-029","volume":"174","author":"Z Chagla","year":"2021","unstructured":"Chagla Z (2021) In adults, the Oxford\/AstraZeneca vaccine had 70% efficacy against COVID-19 >14 d after the 2nd dose. Ann Intern Med 174(3):JC29. https:\/\/doi.org\/10.7326\/ACPJ202103160-029","journal-title":"Ann Intern Med"},{"issue":"10269","key":"5662_CR85","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/S0140-6736(20)32623-4","volume":"397","author":"MD Knoll","year":"2021","unstructured":"Knoll MD, Wonodi C (2021) Oxford-AstraZeneca COVID-19 vaccine efficacy. Lancet 397(10269):72\u201374. https:\/\/doi.org\/10.1016\/S0140-6736(20)32623-4","journal-title":"Lancet"},{"issue":"12","key":"5662_CR86","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.653786.PMID:33981305;PMCID:PMC8107358","volume":"26","author":"GC Rom\u00e1n","year":"2021","unstructured":"Rom\u00e1n GC, Gracia F, Torres A, Palacios A, Gracia K, Harris D (2021) Acute transverse myelitis (ATM):clinical review of 43 patients with COVID-19-associated ATM and 3 post-vaccination ATM serious adverse events with the ChAdOx1 nCoV-19 vaccine (AZD1222). Front Immunol 26(12):653786. https:\/\/doi.org\/10.3389\/fimmu.2021.653786.PMID:33981305;PMCID:PMC8107358","journal-title":"Front Immunol"},{"issue":"3","key":"5662_CR87","first-page":"143","volume":"23","author":"A Shemer","year":"2021","unstructured":"Shemer A, Pras E, Hecht I (2021) Peripheral facial nerve palsy following BNT162b2 (COVID-19) vaccination. Isr Med Assoc J 23(3):143\u2013144 (PMID: 33734623)","journal-title":"Isr Med Assoc J"},{"key":"5662_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbih.2021.100217","volume":"13","author":"M Repajic","year":"2021","unstructured":"Repajic M, Lai XL, Xu P, Liu A (2021) Bell\u2019s Palsy after second dose of Pfizer COVID-19 vaccination in a patient with history of recurrent Bell\u2019s palsy. Brain Behav Immun Health 13:100217. https:\/\/doi.org\/10.1016\/j.bbih.2021.100217","journal-title":"Brain Behav Immun Health"},{"key":"5662_CR89","doi-asserted-by":"publisher","unstructured":"Colella G, Orlandi M, Cirillo N. 2021 Bell\u2019s palsy following COVID-19 vaccination [published online ahead of print, 2021 Feb 21]. J Neurol. 1\u20133. doi:https:\/\/doi.org\/10.1007\/s00415-021-10462-4","DOI":"10.1007\/s00415-021-10462-4"},{"key":"5662_CR90","doi-asserted-by":"publisher","unstructured":"Martin-Villares C, Vazquez-Feito A, Gonzalez-Gimeno MJ, de la Nogal-Fernandez B. 2021 Bell\u2019s palsy following a single dose of mRNA SARS-CoV-2 vaccine: a case report [published online ahead of print, 2021 May 25]. J Neurol. 1\u20132. doi:https:\/\/doi.org\/10.1007\/s00415-021-10617-3","DOI":"10.1007\/s00415-021-10617-3"},{"key":"5662_CR91","doi-asserted-by":"publisher","unstructured":"Nishizawa Y, Hoshina Y, Baker V. 2021 Bell\u2019s palsy following the Ad26.COV2.S COVID-19 vaccination [published online ahead of print, 2021 May 20]. QJM.;hcab143. doi:https:\/\/doi.org\/10.1093\/qjmed\/hcab143","DOI":"10.1093\/qjmed\/hcab143"},{"key":"5662_CR92","doi-asserted-by":"publisher","unstructured":"G\u00f3mez de Terreros Caro G, D\u00edaz SG, Al\u00e9 MP, Gimeno LM. 2021 PAR\u00c1LISIS DE BELL TRAS VACUNACI\u00d3N COVID19: A PROP\u00d3SITO DE UN CASO [BELL\u00b4S PALSY FOLLOWING COVID-19 VACCINATION: A CASE REPORT] [published online ahead of print, 2021 Apr 12]. Neurologia (Engl Ed).\u00a0https:\/\/doi.org\/10.1016\/j.nrl.2021.04.004.","DOI":"10.1016\/j.nrl.2021.04.004"},{"issue":"7","key":"5662_CR93","doi-asserted-by":"publisher","first-page":"e243829","DOI":"10.1136\/bcr-2021-243829","volume":"14","author":"A Burrows","year":"2021","unstructured":"Burrows A, Bartholomew T, Rudd J, Walker D (2021) Sequential contralateral facial nerve palsies following COVID-19 vaccination first and second doses. BMJ Case Rep. 14(7):e243829. https:\/\/doi.org\/10.1136\/bcr-2021-243829","journal-title":"BMJ Case Rep."},{"issue":"11","key":"5662_CR94","doi-asserted-by":"publisher","first-page":"4397","DOI":"10.1007\/s10072-021-05496-5","volume":"42","author":"M Obermann","year":"2021","unstructured":"Obermann M, Krasniqi M, Ewers N, Fayad J, Haeberle U (2021) Bell\u2019s palsy following COVID-19 vaccination with high CSF antibody response. Neurol Sci 42(11):4397\u20134399. https:\/\/doi.org\/10.1007\/s10072-021-05496-5","journal-title":"Neurol Sci"},{"issue":"6","key":"5662_CR95","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.15935","volume":"13","author":"H Iftikhar","year":"2021","unstructured":"Iftikhar H, Noor SU, Masood M et al (2021) Bell\u2019s palsy after 24 hours of mRNA-1273 SARS-CoV-2 vaccine. Cureus 13(6):e15935. https:\/\/doi.org\/10.7759\/cureus.15935","journal-title":"Cureus"},{"key":"5662_CR96","doi-asserted-by":"publisher","unstructured":"Ozonoff A, Nanishi E, Levy O. 2021 Bell's palsy and SARS-CoV-2 vaccines-an unfolding story \u2013 authors\u2019 reply [published online ahead of print, 2021 Jun 7]. Lancet Infect Dis S1473\u20133099(21)00323\u20136. doi:https:\/\/doi.org\/10.1016\/S1473-3099(21)00323-6","DOI":"10.1016\/S1473-3099(21)00323-6"},{"issue":"8","key":"5662_CR97","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1001\/jamaoto.2021.1259","volume":"147","author":"A Shemer","year":"2021","unstructured":"Shemer A, Pras E, Einan-Lifshitz A, Dubinsky-Pertzov B, Hecht I (2021) Association of COVID-19 vaccination and facial nerve palsy: a case-control study. JAMA Otolaryngol Head Neck Surg 147(8):739\u2013743. https:\/\/doi.org\/10.1001\/jamaoto.2021.1259","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"4","key":"5662_CR98","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/S1473-3099(21)00076-1","volume":"21","author":"A Ozonoff","year":"2021","unstructured":"Ozonoff A, Nanishi E, Levy O (2021) Bell\u2019s palsy and SARS-CoV-2 vaccines. Lancet Infect Dis 21(4):450\u2013452. https:\/\/doi.org\/10.1016\/S1473-3099(21)00076-1","journal-title":"Lancet Infect Dis"},{"key":"5662_CR99","doi-asserted-by":"publisher","unstructured":"Konstantinidis I, Tsakiropoulou E, H\u00e4hner A, de With K, Poulas K, Hummel T. 2021 Olfactory dysfunction after coronavirus disease 2019 (COVID-19) vaccination [published online ahead of print, 2021 May 28]. Int Forum Allergy Rhinol.\u00a0https:\/\/doi.org\/10.1002\/alr.22809.","DOI":"10.1002\/alr.22809"},{"issue":"3","key":"5662_CR100","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/RMR.0000000000000287","volume":"30","author":"G Keir","year":"2021","unstructured":"Keir G, Maria NI, Kirsch CFE (2021) Unique imaging findings of neurologic phantosmia following Pfizer-BioNtech COVID-19 vaccination: a case report. Top Magn Reson Imaging 30(3):133\u2013137. https:\/\/doi.org\/10.1097\/RMR.0000000000000287","journal-title":"Top Magn Reson Imaging"},{"key":"5662_CR101","doi-asserted-by":"publisher","unstructured":"Reyes-Capo DP, Stevens SM, Cavuoto KM. 2021 Acute abducens nerve palsy following COVID-19 vaccination [published online ahead of print, 2021 May 24]. J AAPOS S1091\u20138531(21)00109\u20139. doi:https:\/\/doi.org\/10.1016\/j.jaapos.2021.05.003","DOI":"10.1016\/j.jaapos.2021.05.003"},{"key":"5662_CR102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14992027.2021.1931969","volume":"13","author":"D Parrino","year":"2021","unstructured":"Parrino D, Frosolini A, Gallo C, De Siati RD, Spinato G, de Filippis C (2021) Tinnitus following COVID-19 vaccination: report of three cases. Int J Audiol 13:1\u20134","journal-title":"Int J Audiol"},{"key":"5662_CR103","doi-asserted-by":"publisher","unstructured":"Tseng PT, Chen TY, Sun YS, Chen YW, Chen JJ. 2021 The reversible tinnitus and cochleopathy followed first-dose AstraZeneca COVID-19 vaccination [published online ahead of print, 2021 Jul 23]. QJM hcab210. doi:https:\/\/doi.org\/10.1093\/qjmed\/hcab210","DOI":"10.1093\/qjmed\/hcab210"},{"issue":"6","key":"5662_CR104","doi-asserted-by":"publisher","first-page":"e242344","DOI":"10.1136\/bcr-2021-242344","volume":"14","author":"K Narasimhalu","year":"2021","unstructured":"Narasimhalu K, Lee WC, Salkade PR, De Silva DA (2021) Trigeminal and cervical radiculitis after tozinameran vaccination against COVID-19. BMJ Case Rep 14(6):e242344. https:\/\/doi.org\/10.1136\/bcr-2021-242344","journal-title":"BMJ Case Rep"},{"issue":"9","key":"5662_CR105","doi-asserted-by":"publisher","first-page":"e1213","DOI":"10.1097\/MAO.0000000000003275","volume":"42","author":"H Wichova","year":"2021","unstructured":"Wichova H, Miller ME, Derebery MJ (2021) Otologic manifestations after COVID-19 vaccination: the house ear clinic experience. Otol Neurotol 42(9):e1213\u2013e1218. https:\/\/doi.org\/10.1097\/MAO.0000000000003275","journal-title":"Otol Neurotol"},{"issue":"9","key":"5662_CR106","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s00011-021-01476-9","volume":"70","author":"LS Santovito","year":"2021","unstructured":"Santovito LS, Pinna G (2021) Acute reduction of visual acuity and visual field after Pfizer-BioNTech COVID-19 vaccine 2nd dose: a case report. Inflamm Res 70(9):931\u2013933. https:\/\/doi.org\/10.1007\/s00011-021-01476-9","journal-title":"Inflamm Res"},{"key":"5662_CR107","doi-asserted-by":"publisher","first-page":"n1786","DOI":"10.1136\/bmj.n1786","volume":"374","author":"O Dyer","year":"2021","unstructured":"Dyer O (2021) Covid-19: Regulators warn that rare Guillain-Barr\u00e9 cases may link to J&J and AstraZeneca vaccines. BMJ 374:n1786. https:\/\/doi.org\/10.1136\/bmj.n1786","journal-title":"BMJ"},{"key":"5662_CR108","doi-asserted-by":"publisher","unstructured":"M\u00e1rquez Loza AM, Holroyd KB, Johnson SA, Pilgrim DM, Amato AA. Guillain- Barr\u00e9 syndrome in the placebo and active arms of a COVID-19 vaccine clinical trial: temporal associations do not imply causality [published online ahead of print, 2021 Apr 6]. Neurology. 2021.\u00a0https:\/\/doi.org\/10.1212\/WNL.0000000000011881.","DOI":"10.1212\/WNL.0000000000011881"},{"key":"5662_CR109","unstructured":"FDA Briefing Document Janssen Ad26.COV2.S Vaccine for the prevention of COVID-1.26 February 2021. Vaccines and Related Biological Products Advisory Committee Meeting. &It; https:\/\/www.fda.gov\/media\/146217\/download. Accessed 24 June 2021"},{"issue":"2","key":"5662_CR110","doi-asserted-by":"publisher","first-page":"e13426","DOI":"10.7759\/cureus.13426","volume":"13","author":"S Waheed","year":"2021","unstructured":"Waheed S, Bayas A, Hindi F, Rizvi Z, Espinosa PS (2021) Neurological complications of COVID-19: Guillain-Barre syndrome following Pfizer COVID-19 vaccine. Cureus. 13(2):e13426. https:\/\/doi.org\/10.7759\/cureus.13426","journal-title":"Cureus."},{"key":"5662_CR111","doi-asserted-by":"publisher","unstructured":"M\u00e1rquez Loza AM, Holroyd KB, Johnson SA, Pilgrim DM, Amato AA. 2021 Guillain-Barr\u00e9 syndrome in the placebo and active arms of a COVID-19 vaccine clinical trial: temporal associations do not imply causality [published online ahead of print, 2021 Apr 6]. Neurology.\u00a0https:\/\/doi.org\/10.1212\/WNL.0000000000011881.","DOI":"10.1212\/WNL.0000000000011881"},{"issue":"4","key":"5662_CR112","doi-asserted-by":"publisher","first-page":"e242956","DOI":"10.1136\/bcr-2021-242956","volume":"14","author":"SU Patel","year":"2021","unstructured":"Patel SU, Khurram R, Lakhani A, Quirk B (2021) Guillain-Barre syndrome following the first dose of the chimpanzee adenovirus-vectored COVID-19 vaccine, ChAdOx1. BMJ Case Rep. 14(4):e242956. https:\/\/doi.org\/10.1136\/bcr-2021-242956","journal-title":"BMJ Case Rep."},{"key":"5662_CR113","doi-asserted-by":"publisher","unstructured":"Razok A, Shams A, Almeer A et al. 2021 Post-COVID-19 vaccine Guillain-Barr\u00e9 syndrome; first reported case from Qatar. Authorea. May 07,. DOI: https:\/\/doi.org\/10.22541\/au.162041666.65803989\/v1","DOI":"10.22541\/au.162041666.65803989\/v1"},{"key":"5662_CR114","doi-asserted-by":"publisher","DOI":"10.1016\/j.idcr.2021.e01143","volume":"24","author":"O Ogbebor","year":"2021","unstructured":"Ogbebor O, Seth H, Min Z, Bhanot N (2021) Guillain-Barr\u00e9 syndrome following the first dose of SARS-CoV-2 vaccine: a temporal occurrence, not a causal association. IDCases 24:e01143. https:\/\/doi.org\/10.1016\/j.idcr.2021.e01143","journal-title":"IDCases"},{"key":"5662_CR115","doi-asserted-by":"publisher","first-page":"3619131","DOI":"10.1155\/2021\/3619131","volume":"2021","author":"J Finsterer","year":"2021","unstructured":"Finsterer J (2021) Exacerbating Guillain-Barr\u00e9 syndrome eight days after vector-based COVID-19 vaccination. Case Rep Infect Dis 2021:3619131. https:\/\/doi.org\/10.1155\/2021\/3619131","journal-title":"Case Rep Infect Dis"},{"issue":"2","key":"5662_CR116","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1002\/ana.26143","volume":"90","author":"BV Maramattom","year":"2021","unstructured":"Maramattom BV, Krishnan P, Paul R et al (2021) Guillain-Barr\u00e9 syndrome following ChAdOx1-S\/nCoV-19 vaccine. Ann Neurol 90(2):312\u2013314. https:\/\/doi.org\/10.1002\/ana.26143","journal-title":"Ann Neurol"},{"key":"5662_CR117","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26144","author":"CM Allen","year":"2021","unstructured":"Allen CM, Ramsamy S, Tarr AW, Tighe PJ, Irving WL, Tanasescu R, Evans JR (2021) Guillain-Barr\u00e9 syndrome variant occurring after SARS-CoV-2 vaccination. Ann Neurol. https:\/\/doi.org\/10.1002\/ana.26144","journal-title":"Ann Neurol"},{"issue":"1","key":"5662_CR118","doi-asserted-by":"publisher","first-page":"20","DOI":"10.9734\/ijmpcr\/2021\/v14i130124","volume":"14","author":"S Kohli","year":"2021","unstructured":"Kohli S, Varshney M, Mangla S, Jaiswal B, Chhabra PH (2021) Guillain-Barr\u00e9 syndrome after COVID-19 vaccine: should we assume a causal Link? International Journal of Medical and Pharmaceutical Case Reports 14(1):20\u201324. https:\/\/doi.org\/10.9734\/ijmpcr\/2021\/v14i130124","journal-title":"International Journal of Medical and Pharmaceutical Case Reports"},{"issue":"8","key":"5662_CR119","doi-asserted-by":"publisher","first-page":"424","DOI":"10.12691\/ajmcr-9-8-10","volume":"9","author":"S Azam","year":"2021","unstructured":"Azam S, Khalil A, Taha A (2021) Guillain-Barr\u00e9 syndrome in a 67-year-old male post COVID-19 vaccination (Astra Zeneca). American Journal of Medical Case Reports 9(8):424\u2013427","journal-title":"American Journal of Medical Case Reports"},{"issue":"6","key":"5662_CR120","doi-asserted-by":"publisher","first-page":"e243629","DOI":"10.1136\/bcr-2021-243629","volume":"14","author":"T Hasan","year":"2021","unstructured":"Hasan T, Khan M, Khan F, Hamza G (2021) Case of Guillain-Barr\u00e9 syndrome following COVID-19 vaccine. BMJ Case Rep 14(6):e243629. https:\/\/doi.org\/10.1136\/bcr-2021-243629","journal-title":"BMJ Case Rep"},{"key":"5662_CR121","doi-asserted-by":"publisher","unstructured":"Theuriet J, Richard C, Becker J, Pegat A, Bernard E, Vukusic S. 2021 Guillain-Barr\u00e9 syndrome following first injection of ChAdOx1 nCoV-19 vaccine: First report. Rev Neurol (Paris) S0035\u20133787(21)00585\u20133 doi:https:\/\/doi.org\/10.1016\/j.neurol.2021.04.005","DOI":"10.1016\/j.neurol.2021.04.005"},{"key":"5662_CR122","doi-asserted-by":"publisher","unstructured":"Bonifacio GB, Patel D, Cook S, et al. 2021 Bilateral facial weakness with paraesthesia variant of Guillain-Barr\u00e9 syndrome following Vaxzevria COVID-19 vaccine [published online ahead of print, 2021 Jul 14]. J Neurol Neurosurg Psychiatry jnnp-2021\u2013327027. doi:https:\/\/doi.org\/10.1136\/jnnp-2021-327027","DOI":"10.1136\/jnnp-2021-327027"},{"issue":"11","key":"5662_CR123","doi-asserted-by":"publisher","first-page":"4747","DOI":"10.1007\/s10072-021-05467-w","volume":"42","author":"NA Nasuelli","year":"2021","unstructured":"Nasuelli NA, De Marchi F, Cecchin M et al (2021) A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV-19 vaccine. Neurol Sci 42(11):4747\u20134749. https:\/\/doi.org\/10.1007\/s10072-021-05467-w","journal-title":"Neurol Sci"},{"issue":"7","key":"5662_CR124","doi-asserted-by":"publisher","first-page":"e16612","DOI":"10.7759\/cureus.16612","volume":"13","author":"E Jain","year":"2021","unstructured":"Jain E, Pandav K, Regmi P et al (2021) Facial diplegia: a rare, atypical variant of Guillain-Barr\u00e9 syndrome and Ad26.COV2.S Vaccine. Cureus 13(7):e16612. https:\/\/doi.org\/10.7759\/cureus.16612","journal-title":"Cureus"},{"issue":"7","key":"5662_CR125","doi-asserted-by":"publisher","first-page":"e244125","DOI":"10.1136\/bcr-2021-244125","volume":"14","author":"N McKean","year":"2021","unstructured":"McKean N, Chircop C (2021) Guillain-Barr\u00e9 syndrome after COVID-19 vaccination. BMJ Case Rep 14(7):e244125. https:\/\/doi.org\/10.1136\/bcr-2021-244125","journal-title":"BMJ Case Rep"},{"key":"5662_CR126","doi-asserted-by":"publisher","unstructured":"Bonifacio GB, Patel D, Cook S, et al. 2021 Bilateral facial weakness with paraesthesia variant of Guillain-Barr\u00e9 syndrome following Vaxzevria COVID-19 vaccine [published online ahead of print, 2021 Jul 14]. J Neurol Neurosurg Psychiatry jnnp-2021\u2013327027. doi:https:\/\/doi.org\/10.1136\/jnnp-2021-327027","DOI":"10.1136\/jnnp-2021-327027"},{"issue":"1","key":"5662_CR127","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1002\/mus.27251","volume":"64","author":"W Waheed","year":"2021","unstructured":"Waheed W, Carey ME, Tandan SR, Tandan R (2021) Post COVID-19 vaccine small fiber neuropathy. Muscle Nerve 64(1):E1\u2013E2. https:\/\/doi.org\/10.1002\/mus.27251","journal-title":"Muscle Nerve"},{"issue":"1","key":"5662_CR128","doi-asserted-by":"publisher","first-page":"E3","DOI":"10.1002\/mus.27255","volume":"64","author":"S Mahajan","year":"2021","unstructured":"Mahajan S, Zhang F, Mahajan A, Zimnowodzki S (2021) Parsonage Turner syndrome after COVID-19 vaccination. Muscle Nerve 64(1):E3\u2013E4. https:\/\/doi.org\/10.1002\/mus.27255","journal-title":"Muscle Nerve"},{"key":"5662_CR129","doi-asserted-by":"publisher","unstructured":"Diaz-Segarra N, Edmond A, Gilbert C, Mckay O, Kloepping C, Yonclas P. 2021 Painless idiopathic neuralgic amyotrophy after COVID-19 vaccination: a case report [published online ahead of print, 2021 Apr 22]. PM R.;https:\/\/doi.org\/10.1002\/pmrj.12619","DOI":"10.1002\/pmrj.12619"},{"issue":"7","key":"5662_CR130","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.nrl.2021.05.007","volume":"36","author":"J Antonio Crespo Burillo","year":"2021","unstructured":"Antonio Crespo Burillo J, Mart\u00ednez CL, Arguedas CG, Pueyo FJM (2021) Neuralgia amiotr\u00f3fica secundaria a vacuna contra COVID-19 Vaxzevria (AstraZeneca) [Amyotrophic neuralgia secondary to Vaxzevria (AstraZeneca) COVID-19 vaccine]. Neurologia 36(7):571\u2013572. https:\/\/doi.org\/10.1016\/j.nrl.2021.05.007","journal-title":"Neurologia"},{"issue":"1","key":"5662_CR131","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jaad.2021.03.092","volume":"85","author":"DE McMahon","year":"2021","unstructured":"McMahon DE, Amerson E, Rosenbach M et al (2021) Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases. J Am Acad Dermatol 85(1):46\u201355. https:\/\/doi.org\/10.1016\/j.jaad.2021.03.092","journal-title":"J Am Acad Dermatol"},{"key":"5662_CR132","doi-asserted-by":"publisher","unstructured":"Arora P, Sardana K, Mathachan SR, Malhotra P. 2021 Herpes zoster after inactivated COVID-19 vaccine: a cutaneous adverse effect of the vaccine [published online ahead of print, 2021 Jun 2]. J Cosmet Dermatol. https:\/\/doi.org\/10.1111\/jocd.14268.","DOI":"10.1111\/jocd.14268"},{"key":"5662_CR133","doi-asserted-by":"publisher","unstructured":"Llad\u00f3 I, Fern\u00e1ndez-Bern\u00e1ldez A, Rodr\u00edguez-Jim\u00e9nez P 2021. \"Varicella zoster virus reactivation and mRNA vaccines as a trigger\". Reply to: Herpes-Zoster reactivation after mRNA-1273 (Moderna) SARS-CoV-2 Vaccination [published online ahead of print, 2021 Jul 22]. JAAD Case Rep.\u00a0https:\/\/doi.org\/10.1016\/j.jdcr.2021.07.011.","DOI":"10.1016\/j.jdcr.2021.07.011"},{"issue":"10","key":"5662_CR134","doi-asserted-by":"publisher","first-page":"e620","DOI":"10.1111\/jdv.17422","volume":"35","author":"I Tessas","year":"2021","unstructured":"Tessas I, Kluger N (2021) Ipsilateral herpes zoster after the first dose of BNT162b2 mRNA COVID-19 vaccine. J Eur Acad Dermatol Venereol 35(10):e620\u2013e622. https:\/\/doi.org\/10.1111\/jdv.17422","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"5662_CR135","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jdcr.2021.04.014","volume":"12","author":"P Rodr\u00edguez-Jim\u00e9nez","year":"2021","unstructured":"Rodr\u00edguez-Jim\u00e9nez P, Chicharro P, Cabrera LM et al (2021) Varicella-zoster virus reactivation after SARS-CoV-2 BNT162b2 mRNA vaccination: Report of 5 cases. JAAD Case Rep 12:58\u201359. https:\/\/doi.org\/10.1016\/j.jdcr.2021.04.014","journal-title":"JAAD Case Rep"},{"key":"5662_CR136","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27036","author":"E Eid","year":"2021","unstructured":"Eid E, Abdullah L, Kurban M, Abbas O (2021) Herpes zoster emergence following mRNA COVID-19 vaccine. J Med Virol. https:\/\/doi.org\/10.1002\/jmv.27036","journal-title":"J Med Virol"},{"issue":"6","key":"5662_CR137","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1111\/jocd.14035","volume":"20","author":"E Bostan","year":"2021","unstructured":"Bostan E, Yalici-Armagan B (2021) Herpes zoster following inactivated COVID-19 vaccine: a coexistence or coincidence? J Cosmet Dermatol 20(6):1566\u20131567. https:\/\/doi.org\/10.1111\/jocd.14035","journal-title":"J Cosmet Dermatol"},{"key":"5662_CR138","doi-asserted-by":"publisher","unstructured":"Furer V, Zisman D, Kibari A, Rimar D, Paran Y, Elkayam O. 2021 Herpes zoster following BNT162b2 mRNA Covid-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: a case series [published online ahead of print, 2021 Apr 12]. Rheumatology (Oxford) keab345. doi:https:\/\/doi.org\/10.1093\/rheumatology\/keab345","DOI":"10.1093\/rheumatology\/keab345"},{"issue":"2","key":"5662_CR139","doi-asserted-by":"publisher","first-page":"198","DOI":"10.7774\/cevr.2021.10.2.198","volume":"10","author":"SB Aksu","year":"2021","unstructured":"Aksu SB, \u00d6zt\u00fcrk GZ (2021) A rare case of shingles after COVID-19 vaccine: is it a possible adverse effect? Clin Exp Vaccine Res 10(2):198\u2013201. https:\/\/doi.org\/10.7774\/cevr.2021.10.2.198","journal-title":"Clin Exp Vaccine Res"},{"key":"5662_CR140","doi-asserted-by":"publisher","unstructured":"Chiu HH, Wei KC, Chen A, Wang WH. 2021 Herpes zoster following COVID-19 vaccine: report of 3 cases [published online ahead of print, 2021 Jul 22]. QJM.;hcab208.\u00a0https:\/\/doi.org\/10.1093\/qjmed\/hcab208","DOI":"10.1093\/qjmed\/hcab208"},{"issue":"11","key":"5662_CR141","doi-asserted-by":"publisher","first-page":"e750","DOI":"10.1111\/jdv.17555","volume":"35","author":"M Alpalh\u00e3o","year":"2021","unstructured":"Alpalh\u00e3o M, Filipe P (2021) Herpes Zoster following SARS-CoV-2 vaccination - a series of 4 cases. J Eur Acad Dermatol Venereol 35(11):e750\u2013e752. https:\/\/doi.org\/10.1111\/jdv.17555","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"5662_CR142","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jdcr.2021.05.042","volume":"15","author":"L Channa","year":"2021","unstructured":"Channa L, Torre K, Rothe M (2021) Letter to the editor: Herpes-Zoster reactivation after mRNA-1273 (Moderna) SARS-CoV-2 Vaccination. JAAD Case Rep 15:60\u201361. https:\/\/doi.org\/10.1016\/j.jdcr.2021.05.042","journal-title":"JAAD Case Rep"},{"key":"5662_CR143","doi-asserted-by":"publisher","first-page":"hcab077","DOI":"10.1093\/qjmed\/hcab077","volume":"19","author":"A Tan","year":"2021","unstructured":"Tan A, Stepien KM, Narayana STK (2021) Carnitine palmitoyltransferase II deficiency and post-COVID vaccination rhabdomyolysis. QJM 19:hcab077. https:\/\/doi.org\/10.1093\/qjmed\/hcab077","journal-title":"QJM"},{"issue":"5","key":"5662_CR144","doi-asserted-by":"publisher","first-page":"e15004","DOI":"10.7759\/cureus.15004","volume":"13","author":"M Mack","year":"2021","unstructured":"Mack M, Nichols L, Guerrero DM (2021) Rhabdomyolysis secondary to COVID-19 vaccination. Cureus 13(5):e15004. https:\/\/doi.org\/10.7759\/cureus.15004","journal-title":"Cureus"},{"issue":"4","key":"5662_CR145","doi-asserted-by":"publisher","first-page":"102170","DOI":"10.1016\/j.dsx.2021.06.007","volume":"15","author":"M Nassar","year":"2021","unstructured":"Nassar M, Chung H, Dhayaparan Y et al (2021) COVID-19 vaccine induced rhabdomyolysis: Case report with literature review. Diabetes Metab Syndr. 15(4):102170. https:\/\/doi.org\/10.1016\/j.dsx.2021.06.007","journal-title":"Diabetes Metab Syndr."},{"issue":"424","key":"5662_CR146","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1093\/qjmed\/hcab043","volume":"1146","author":"DJ Theodorou","year":"2021","unstructured":"Theodorou DJ, Theodorou SJ, Axiotis A, Gianniki M, Tsifetaki N (2021) COVID-19 vaccine-related myositis. QJM 1146(424):425. https:\/\/doi.org\/10.1093\/qjmed\/hcab043","journal-title":"QJM"},{"key":"5662_CR147","doi-asserted-by":"publisher","first-page":"hcab161","DOI":"10.1093\/qjmed\/hcab161","volume":"9","author":"IRB Godoy","year":"2021","unstructured":"Godoy IRB, Rodrigues TC, Skaf A (2021) Myositis ossificans following COVID-19 vaccination. QJM 9:hcab161. https:\/\/doi.org\/10.1093\/qjmed\/hcab161","journal-title":"QJM"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-021-05662-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-021-05662-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-021-05662-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T18:38:49Z","timestamp":1641235129000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-021-05662-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,31]]},"references-count":147,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["5662"],"URL":"https:\/\/doi.org\/10.1007\/s10072-021-05662-9","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,31]]},"assertion":[{"value":"4 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}